Resolve Therapeutics Lands $2,000,000 Series A Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb3d6987-f8f0-4dcb-9cf8-9a35785c8e87&Preview=1
Date 5/17/2011
Company Name Resolve Therapeutics
Mailing Address 5400 Carillon Point Kirkland, WA 98033
Company Description Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy.